Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4212 USD | -4.25% | -7.59% | -26.75% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 8.11M 647M |
---|---|---|---|---|---|
Net income 2024 * | -4M -319M | Net income 2025 * | -13M -1.04B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.48
x | P/E ratio 2025 * |
-1.4
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.29% |
Latest transcript on Virios Therapeutics, Inc.
1 day | -4.25% | ||
1 week | -7.59% | ||
Current month | -6.81% | ||
1 month | -22.00% | ||
3 months | +5.30% | ||
6 months | -48.01% | ||
Current year | -26.75% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 31/12/17 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 31/03/20 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 31/03/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 20/12/20 |
Richard Whitley
BRD | Director/Board Member | 78 | 20/12/20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 31/12/17 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 0.4212 | -4.25% | 133,260 |
01/05/24 | 0.4399 | -2.67% | 27,150 |
30/04/24 | 0.452 | -3.80% | 37,705 |
29/04/24 | 0.4698 | +0.06% | 73,584 |
26/04/24 | 0.4695 | +3.01% | 40,647 |
Delayed Quote Nasdaq, May 02, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.75% | 8.47M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- VIRI Stock